LUNGevity part of Winning Cancer Grand Challenge Team
|
LUNGevity is honored to be the US patient advocacy organization that is part of the new Cancer Grand Challenges team taking on the challenge of cancer cachexia, a wasting syndrome associated with late-stage cancer. |
|
The Cancer Cachexia Action Network (CANCAN) team, with investigators from the UK and US, is receiving $25M to tackle this critical obstacle in cancer research. Cachexia is responsible for up to 30% of cancer deaths, and is estimated to affect 50% of lung cancer patients.
The Cancer Cachexia Action Network represents the world’s first virtual institute with a mission to solve cancer cachexia.
Takeaways from the Annual ASCO Meeting
Dr. Upal Basu Roy, Executive Director of LUNGevity Research, hosted a conversation with Dr. Charles Rudin, Professor and Chief, Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and Chair, LUNGevity Scientific Advisory Board, to talk about patient takeaways from the American Society of Clinical Oncology (ASCO) Conference.
In this video interview, they discuss second-line clinical trial drugs, immunotherapy, and answer questions from patients and caregivers.
New Rare Mutations Gateway Launch
|
|
LUNGevity is proud to announce that we have launched a new Patient Gateway, specifically created for people with rare mutations and fusions (ROS1, MET, RET, NTRK, BRAF, and more). Like the other Patient Gateways, the Rare Mutations and Fusions Gateway is a central hub for information, news, events, and expert webinars. |
Be sure to visit the Gateways and sign up for the specialty newsletters to stay updated on new treatments and more.
Other gateways for specific types of lung cancer include:
- KRAS
- Non-Small Cell Lung Cancer
- ALK
- EGFR
International Lung Cancer Survivorship Conference
Registration is now open for the annual International Lung Cancer Survivorship Conference, happening July 15-16. This online education-focused event for lung cancer patients and caregivers is free to attend.
Join the keynote kick-off on Friday morning to hear from Dr. David Carbone, renowned lung cancer researcher, medical oncologist at Ohio State University (OSU), and Director of the James Thoracic Oncology Center at the OSU Medical Center.
We will be joined by many other medical experts to host sessions on:
- Optimizing Your Lung Cancer Care
- Participating in Research Studies
- Medical Marijuana Q&A
- Ask the Experts – Your Specific Biomarker/Mutation
- Ask the Experts – Radiation and Chemotherapy
- And more...
Breathe Deep TOGETHER
Join us for Breathe Deep TOGETHER, a nationwide walk that brings our community TOGETHER for a morning of celebration, hope, and remembrance for all those affected by lung cancer. Register now and raise $25 by July 15 to receive a LUNGevity fleece headband. It’s the perfect headwear for when we gather and walk on November 5, 2022.
Clinical Trial Update: Second-Line Lung Cancer Treatments
|
Dr. Upal Basu Roy joined Ruth Fein of Patient Power to discuss three promising new clinical trials providing hope for patients whose first-line lung cancer treatments are failing. In this short conversation, they discuss who these treatments can help and how soon they may be available. |
|
Upcoming Events
Be sure to visit our events calendar for Virtual Meetup groups, and upcoming Facebook Live events featuring experts and patient stories.
A reminder that on the Patient Gateways we post events specific to people with a known biomarker.
